Evidence map›Paper›PMID 38809017›Full record

ArticleMicrobiology spectrum2024

The usefulness of nanopore sequencing in whole-genome sequencing-based genotyping of

Yu-Ping Hong, Bo-Han Chen, You-Wun Wang, Ru-Hsiou Teng, Hsiao-Lun Wei, Chien-Shun Chiou

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Nanopore sequencing in veterinary medicine: from concepts to clinical applications.Frontiers in cellular and infection microbiology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Oxford Nanopore's 2024 sequencing technology forJournal of clinical microbiology · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu-Ping HongCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Taichung, Taiwan.
Bo-Han ChenCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Taichung, Taiwan.
You-Wun WangCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Taichung, Taiwan.
Ru-Hsiou TengCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Taichung, Taiwan.
Hsiao-Lun WeiCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Taichung, Taiwan.
Chien-Shun ChiouCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Taichung, Taiwan.ORCID 0000-0003-3674-1030

Funding

Ministry of Health and Welfare (MOHW) MOHW110-CDC-C-315-113107, MOHW111-CDC-C-315-123108, MOHW112-CDC-C-315-133116, MOHW113-CDC-C-315-144316
6 · The paper itself

Abstract

Bacterial genotyping through whole-genome sequencing plays a crucial role in disease surveillance and outbreak investigations in public health laboratories. This study assessed the effectiveness of Oxford Nanopore Technologies (ONT) sequencing in the genotyping of IMPORTANCE: This study unveils that Oxford Nanopore Technologies sequencing, by itself, holds the potential to serve as a whole-genome sequencing-based genotyping tool in public health laboratories, enabling routine subtyping of bacterial isolates for disease surveillance and outbreak investigations.

Indexed as

Genome, BacterialListeria monocytogenesNanopore SequencingSalmonella enteritidisWhole Genome SequencingDisease OutbreaksGenotypeGenotyping TechniquesHumansListeriosisSalmonella InfectionscgMLSTgenotypingListeria monocytogenesONT sequencingSalmonella enterica serovar EnteritidiswgSNPwhole-genome sequencing

Identifiers

PMID38809017
PMCPMC11218467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.